Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opinion & Analysis Theralase Technologies Inc. V.TLT.W


Primary Symbol: V.TLT Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

Opinion & Analysis (TSXV:TLT)

Pharmaceutical company treats bladder cancer with new tech

Ryan Dhillon January 8, 2024

Theralase is raising up to $5.3M to complete bladder cancer study

Coreena Robertson November 6, 2023

For Better or Worse? On the Verge of a New Era in Investing

Stockhouse Editorial April 1, 2021

Buzz on the Bullboards: A Big Picture Look at Small-Cap Opportunities

Stockhouse Editorial February 18, 2021

Buzz on the Bullboards: Tracking the Big Movers of 2020

Stockhouse Editorial December 17, 2020

Buzz on the Bullboards: T’is the Season for a Rebound?

Stockhouse Editorial December 3, 2020

Buzz on the Bullboards: Crisis Creates Opportunity

Stockhouse Editorial November 26, 2020

Buzz on the Bullboards: What Goes Up…

Omri Wallach January 30, 2020

Buzz on the Bullboards: Top Healthcare and Tech

Omri Wallach October 31, 2019

Buzz on the Bullboards: Defying the Markets

Omri Wallach August 16, 2019

Buzz on the Bullboards: Who’s Hot and Who’s Not

Stockhouse Editorial April 12, 2019

Buzz on the Bullboards: Snapshot of Recent Winners/Losers

Stockhouse Editorial February 11, 2019

Buzz on the Bullboards: Investing Success in 2019?

Stockhouse Editorial January 11, 2019

VIDEO: Help for Bladder Cancer Patients

BTV-Business Television July 24, 2018

Buzz on the Bullboards: Hottest Summer Stocks and Trends

Stockhouse Editorial June 21, 2018

Buzz on the Bullboards: Investors Reveal Their Investing Goals

Stockhouse Editorial May 28, 2018

Buzz on the Bullboards: Markets in Turmoil

Stockhouse Editorial February 9, 2018

Buzz on the Bullboards: Isodiol rising

Stockhouse Editorial November 23, 2017

Buzz on the Bullboards: Canopy Growth still on fire

Stockhouse Editorial November 7, 2017

Buzz on the Bullboards: Canopy Growth spikes higher

Stockhouse Editorial October 30, 2017